Dirithromycin NEW
| Price | $31 |
| Package | 500mg |
| Supply Ability: | 10g |
| Update Time: | 2026-05-11 |
Product Details
| Product Name: Dirithromycin | CAS No.: 62013-04-1 |
| Purity: 98.00% | Supply Ability: 10g |
| Release date: 2026/05/11 |
Product Introduction
Bioactivity
| Name | Dirithromycin |
| Description | Dirithromycin (LY237216) is a macrolide glycopeptide antibiotic. It is used to treat many different types of bacterial infections, such as bronchitis, pneumonia, tonsillitis, and even skin infections. |
| In vivo | At therapeutic concentrations, Dirithromycin enhances the production of IL1β in cells stimulated by lipopolysaccharides, with increases of +37% and +28% at 1 μg/mL. At supra-therapeutic concentrations, Dirithromycin inhibits IL1β through the inhibition of protein kinase C; the concentration of Dirithromycin when 50% inhibition is achieved is 378 mg/mL, while for Spiramycin it is 234 mg/mL. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | H2O : < 1 mg/mL (insoluble or slightly soluble) DMSO : 2.09 mg/mL (2.5 mM), Sonication is recommended. Ethanol : 93 mg/mL (111.37 mM), Sonication is recommended. |
| Keywords | macrolide | LY-237216 | LY 237216 | Inhibitor | inhibit | gram-positive | Erythromycin | Dirithromycin | Bacterial | bacteria | ASE-136 | ASE136 | Antibiotic | 70S ribosome | 50S ribosome |
| Inhibitors Related | Neomycin sulfate | Adipic dihydrazide | Levulinic acid | D(+)-Raffinose pentahydrate | Sulfamethoxazole sodium | Terbinafine hydrochloride | Doxycycline | Hyaluronic acid sodium (MW 20 kDa) | Dimethyl sulfoxide | Sodium diacetate | Sodium bicarbonate | BES |
| Related Compound Libraries | FDA-Approved & Pharmacopeia Drug Library | Macrocyclic Compound Library | Bioactive Compound Library | Drug-induced Liver Injury (DILI) Compound Library | Antibiotics Library | Drug Repurposing Compound Library | Microbial Natural Product Library | NO PAINS Compound Library | FDA-Approved Drug Library | Orally Active Compound Library | Bioactive Compounds Library Max | Human Metabolite Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $31.00 |
VIP6Y
|
TargetMol Chemicals Inc.
|
2026-05-11 | |
|
VIP1Y
|
Hefei Lbao Physical & Chemical Science Co.,Ltd
|
2025-11-20 | ||
| $31.00 |
VIP2Y
|
TargetMol Chemicals Inc.
|
2025-04-27 | |
|
VIP2Y
|
Shaanxi Xianhe Biotech Co., Ltd
|
2025-04-22 | ||
| $10.00 |
Hebei Chuanghai Biotechnology Co., Ltd
|
2024-11-27 | ||
|
VIP5Y
|
Sinoway Industrial co., ltd.
|
2024-05-06 | ||
| $230.00 |
Hebei Mingeng Biotechnology Co., Ltd
|
2022-05-05 | ||
| $80.00 |
Hebei baicao biology science and technology co., ltd
|
2022-04-25 | ||
|
VIP6Y
|
WUHAN FORTUNA CHEMICAL CO., LTD
|
2021-10-18 | ||
| $15.00 |
Zhuozhou Wenxi import and Export Co., Ltd
|
2021-08-11 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, USA
INQUIRY